Sotoraib (Sotorasib)

Sotoraib contains the active substance sotorasib and belongs to a group of medicines known as antineoplastic agents (cancer medicines).

 Sotoraib is used to treat adults with a type of lung cancer called non-small cell lung cancer (NSCLC) when it is advanced and has spread to other parts of the body.

 Sotoraib is used when previous treatments were not effective in stopping the growth of the cancer, and when the cancer cells have a genetic change that allows them to produce an abnormal form of protein called KRAS G12C. Your doctor will test your cancer cells for this change beforehand to make sure that Sotoraib is right for you.

 How does Sotoraib work?

 The abnormal KRAS G12C protein, acts to help make cancer cells grow out of control. Sotoraib attaches to the protein and stops it from working, which may slow down or stop the growth of the cancer.

 If you have any questions about how Sotoraib works or why this medicine has been prescribed for you, ask your doctor, pharmacist, or nurse.